- Home
- TRVI vs ESRT Comparison
TRVI vs ESRT Comparison
Compare TRVI & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- ESRT
- Stock Information
- Founded
- TRVI 2011
- ESRT 2011
- Country
- TRVI United States
- ESRT United States
- Employees
- TRVI N/A
- ESRT 667
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- ESRT Real Estate Investment Trusts
- Sector
- TRVI Health Care
- ESRT Real Estate
- Exchange
- TRVI Nasdaq
- ESRT Nasdaq
- Market Cap
- TRVI 1.4B
- ESRT 1.2B
- IPO Year
- TRVI 2019
- ESRT 2013
- Fundamental
- Price
- TRVI $10.91
- ESRT $7.23
- Analyst Decision
- TRVI Strong Buy
- ESRT Hold
- Analyst Count
- TRVI 9
- ESRT 2
- Target Price
- TRVI $20.72
- ESRT $10.65
- AVG Volume (30 Days)
- TRVI 1.6M
- ESRT 1.9M
- Earning Date
- TRVI 11-10-2025
- ESRT 10-29-2025
- Dividend Yield
- TRVI N/A
- ESRT 1.92%
- EPS Growth
- TRVI N/A
- ESRT N/A
- EPS
- TRVI N/A
- ESRT 0.20
- Revenue
- TRVI N/A
- ESRT $766,184,000.00
- Revenue This Year
- TRVI N/A
- ESRT $2.27
- Revenue Next Year
- TRVI N/A
- ESRT $3.04
- P/E Ratio
- TRVI N/A
- ESRT $35.89
- Revenue Growth
- TRVI N/A
- ESRT 1.02
- 52 Week Low
- TRVI $2.36
- ESRT $6.56
- 52 Week High
- TRVI $11.83
- ESRT $11.43
- Technical
- Relative Strength Index (RSI)
- TRVI 55.76
- ESRT 42.57
- Support Level
- TRVI $10.22
- ESRT $7.17
- Resistance Level
- TRVI $11.82
- ESRT $7.46
- Average True Range (ATR)
- TRVI 0.55
- ESRT 0.25
- MACD
- TRVI -0.08
- ESRT -0.04
- Stochastic Oscillator
- TRVI 30.12
- ESRT 17.46
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.